Healthtech Startups
17,195 companies tagged Healthtech, with their investors and founders.
0 investors
Allevion Therapeutics is a medical device company developing technologies in the healthcare and medtech space. Its team has a background in cardiac arrhythmia, atrial fibrillation, and neurological/movement disorder treatments.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Gravity Platform is a cloud-native healthcare operations hub that automates complex clinical and administrative workflows through AI-assisted task management and unified communication channels. The platform integrates with existing healthcare systems via standard protocols and serves healthcare organizations seeking to improve operational efficiency and patient care delivery.
0 investors
0 investors
0 investors
0 investors
Alta Smiles develops the V5x, a smartphone-based imaging device for dental and orthodontic providers to capture high-quality intra and extraoral photos in-office and enable remote patient monitoring during treatment. The system reduces appointment time and improves workflow efficiency for dental practices.
0 investors
AltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Alvee surfaces social and whole-person health needs from clinical data to help care teams provide proactive, personalized care at scale. The company builds AI-driven tools for health systems, payers, and care organizations to identify and act on social determinants of health.
0 investors
0 investors
Alzheon is a clinical-stage biopharmaceutical company developing oral small-molecule drugs for Alzheimer's disease and other neurodegenerative disorders, with a Phase 3 program for its lead compound valiltramiprosate (ALZ-801). It operates an anti-aggregation platform including two clinical-stage oral programs and a small-molecule discovery library.
0 investors
0 investors
0 investors